| Patent # | Subject | Assignee(s) | Inventor(s) | Priority application date | Publication date |
| WO 200589792 | A new recombinant protein comprising polypeptides bearing epitopes of human papilloma virus (HPV) antigens; useful for treating or preventing HPV infection, or for immunotherapy against the onset of malignant transformation due to HPV infection. | BT Pharma (Labège-Innopole, France); INSERM (France); Institut Pasteur (Paris); CNRS (France) | la Dant D, le Clerc C, Preville X, Timmerman B | 3/18/2004 | 9/29/2005 |
| WO 200587813 | A new composition that comprises contacting an antigen-presenting cell with a chimeric antigen comprising an immune response domain and a target binding domain, which comprises a xenotypic antibody fragment; useful for eliciting a T-cell response against hepatitis B virus and hepatitis C virus infections. | ViRexx (Edmonton, Alberta, Canada) | George R, Noujaim A, Tyrrell L, Wang D | 2/24/2004 | 9/22/2005 |
| WO 200587799 | A new isolated polypeptide that binds specifically to an oligosaccharide; useful in preparing a vaccine for treating or preventing HIV infection. | US Dept. of Health & Human Services (Washington, DC, USA) | Bewley CA | 3/9/2004 | 9/22/2005 |
| US 20050202045 | A method for making a recombinant avian herpesvirus, comprising cotransfecting overlapping subgenomic fragments employing the subgenomic clones and enzymes; useful in producing therapeutic or prophylactic vaccines. | Schering-Plough Veterinary Corp. (Kenilworth, NJ, USA) | Cochran MD, Cook SM, Wild MA | 6/14/2001 | 9/15/2005 |
| WO 200585445 | A novel recombinant varicella herpes-zoster virus comprising a bacterial artificial chromosome vector sequence; useful as a vaccine for treating varicella herpes-zoster virus infection. | Osaka University (Osaka, Japan) | Gomi Y, Mori Y, Nagaike K, Takahashi M, Yamaishi K | 3/5/2004 | 9/15/2005 |
| EP 1574517 | A novel recombinant or synthetic hepatitis C virus E1 envelope protein or its portion comprising one or more disulfide bonds between a specific pair of cysteines; useful as vaccine for hepatitis C virus. | Innogenetics (Ghent, Belgium) | Bosman A, Depla E, Depraetere S, Verheyden G | 3/9/2004 | 9/14/2005 |
| WO 200581716 | A novel nucleic acid encoding chimeric polypeptides such as calreticulin and antigenic peptide from severe acute respiratory syndrome (SARS) coronavirus; useful as a DNA vaccine for SARS coronavirus. | Johns Hopkins University (Baltimore, MD, USA) | Hung C, Kim TW, Wu T | 11/24/2003 | 9/9/2005 |
| CN 1616654 | A method for inactivating and purifying SARS virus; useful for preparing vaccines to combat SARS. | Kexing Biological Products (Shenzen, China) | Han Z, Zhang J, Zhang Z | 11/12/2003 | 5/18/2005 |
| CN 1616491 | A new fusion protein useful as a vaccine for treating and preventing influenza. | Qinghua University (Beijing) | Chen Y; Liu W | 9/29/2004 | 5/18/2005 |
| CN 1614011 | A totally enclosed double-circulating column chromatography process for purifying inactivated virus vaccines. | Jiahe Biotechnology (Guangzhou, China) | He C; Le W | 11/6/2003 | 5/11/2005 |
| CN 1613503 | A technique for preparing a virus vaccine using a bioreactor featuring a disk carrier for increasing the surface area used to grow cells, and a better culture condition created for increasing the culture density. | Jiahe Biotechnology (Guangzhou, China) | He C, Zhang J | 11/6/2003 | 5/11/2005 |
| IN 200200194 | Liposomes containing novel peptide antigens; useful for regulating the immune response and for the development of therapeutic agents for the prevention and treatment of hepatitis B virus–associated diseases. | Mogam Biotechnology Research Institute (Yongin, South Korea) | Chang JS, Cheong H, Cho SY, Choi MJ, Hwang Y, Kim TY, Lee KU | 4/3/2002 | 3/11/2005 |
 |
